XtalPi and Pierre Fabre Agree to AI Drug-Discovery Collaboration
XtalPi has reportedly reached a collaboration agreement with French pharmaceutical company Pierre Fabre. [[fact:fact-6107j0kat]]The deal reportedly includes an upfront payment, multiple milestone payments, and subsequent revenue sharing. [[fact:fact-v0dzdw15s]]The companies plan to conduct multiple joint research projects in oncology. [[fact:fact-2smhnqtkd]]The planned work would use XtalPi's AI-and-robotics technology to design novel small molecules from scratch against undisclosed targets and jointly advance clinical candidate discovery. [[fact:fact-07m96hcr4]]XtalPi is reportedly responsible for drug design and delivery, while Pierre Fabre would handle compound screening and subsequent clinical and commercial development. [[fact:fact-hvgwgzakv]]